| Identification | Back Directory | [Name]
4-Bromo-6-[3-(4-chlorophenyl)propoxy]-5-(pyridin-3-ylmethylamino)pyridazin-3(2H)-one hydrochloride (free base) | [CAS]
139145-27-0 | [Synonyms]
Parogrelil
Parogrelil - NT 702, free base | NM 702
4-Bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(3-pyridinylmethyl)amino]-3(2H)-pyridazinone
4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-((pyridin-3-ylmethyl)amino)pyridazin-3(2H)-one
3(2H)-Pyridazinone, 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(3-pyridinylmethyl)amino]-
4-Bromo-6-[3-(4-chlorophenyl)propoxy]-5-(pyridin-3-ylmethylamino)pyridazin-3(2H)-one hydrochloride (free base) | [Molecular Formula]
C19H18BrClN4O2 | [MOL File]
139145-27-0.mol | [Molecular Weight]
449.73 |
| Hazard Information | Back Directory | [Uses]
Parogrelil (NT-702 free base) is a compound with intermittent claudication inhibitory activity that inhibits PDE3, inhibits platelet aggregation and vasoconstriction, and improves walking distance and plantar surface temperature in a rat experimental model. | [References]
[1] NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model DOI:10.1016/j.lfs.2007.07.025 |
|
| Company Name: |
LETOPHARM LIMITED
|
| Telephone: |
+86-21-5821 5861 |
| Website: |
www.letopharm.com |
|